REFERENCE
EMA.Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2010. Media Release: 23 Jul 2010. Available from: URL: http://www.ema.europa.eu
Rights and permissions
About this article
Cite this article
The CHMP has started a review of dexrazoxane-containing products, to assess the possible risk of acute myeloid leukaemia. React. Wkly. 1312, 7 (2010). https://doi.org/10.2165/00128415-201013120-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201013120-00022